pa, I believe you are right. We have seen 40 years of vaccination against influenza and all we have done is to drive the virus into resistant mutations. An effective anti-viral such as Relenza is as effective today against a broad swathe (or is it all?) of the influenza family as it was 10 years ago. It can be used as a prophylactic too - thus competing directly with vaccines. LANI promises to do everything Relenza can do - but with just one dose. This means it can be administered more effectively and is therefor even more of a vaccine substitute. It has a 5 year shelf life (vs 12mths for vaccines), so far as we are aware it has so far proven impossible for the virus to mutate its was out of Relenza's reach (10yrs vs vaccine's 6mths) and with astute usage it could totally defuse a possible epidemic.
Despite being a little overweight this one - I couldn't resist topping up this morning.
BTA Price at posting:
$2.05 Sentiment: Buy Disclosure: Held
